Introduction to CNS pharmacology Flashcards

1
Q

organization of the CNS (outer to inner)

A

cortex: sensory/motor/thought process
limbic system: emotion/memory
diencephalon: endocrine/autonomic
cerebellum: sensory/motor coordination
midbrain: reflex pathways/infromation relay/ awareness/arousal
spinal cord: sensory/motor/autonomic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

types of neurons

A

interneurons - communicate within the same brain region
projection neurons - axons project from one brain region to another

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

how do neurodegenerative diseases arise in the CNS

A

from loss/imbalance of neurons in neurotransmission - drugs attempt to restore balance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

types of CNS neurotransmitters

A
  • amino acids: glutamate, GABA
  • acetylcholine
  • monoamines: dopamine, norepinephrine, seretonin
  • peptides
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

amino acid neurotransmitters

A

glutamate: excitatory at NMDA receptor (cause neurons to fire more)
GABA: inhibitory at GABAa receptor (inhibit neurons from firing)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Glutamate characteristics

A
  • relay neuron through the CNS
  • agonist of NMDA and non-NMDA receptors
  • excitatory effects
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

NMDA receptor

A
  • ion channel - increases Ca2+, Na+ and K+
  • agonist = glutamate
  • antagonist = PCP (a hallucinogen)
  • also has binding sites for glycine, polyamines and zinc
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

The NMDA receptor had modulatory sites for which drugs/molecules

A

PCP
glycine
Ketamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

GABA characteristics

A
  • relay neuron throughout the CNS associated with behaviour
  • agonist at GABAa (and b) receptors
  • inhibitory effects
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

GABAa receptor

A
  • ion channel - increases Cl- in cell (inhibitory)
  • agonist = GABA
  • has sites for barbiturates, benzodiazepine and general anesthetics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

ACh in CNS pharmacology

A
  • ACh is at interneuron associated with motor control
  • ACh at projection neurons associated with learning memory and cognition (lost in Alzheimer’s)
  • Agonist at M and N receptors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Norepinephrine in CNS pharmacology

A
  • found throughout the CNS
  • important in awareness, arousal and autonomic control
  • some antidepresants increase NE
  • agonist as a1, a2 and B1 receptors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

characteristics of dopamine

A
  • precurosor of NE
  • in cortex responsible for motivation/emotion
  • in limbic system responsible for mood/behaviour
  • in midbrain responsible for motor control
  • at D1 receptor increase cAMP, at D2 receptor decrease cAMP
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

characteristics of serotonin

A
  • project from midbrain and brainstem throughout the brain
  • role in behaviour, control of sleep, temperature, appetite and neuroendocrine function
  • Agonist at 5-HT receptor
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

5-HT receptor

A
  • all are G protein linked except 5-HT3 (ion channel)
  • 5-HT1: inhibitory - decrease cAMP
  • 5-HT2: excitatory - increase DAG and IP3
  • main agonist = serotonin
  • agonist at 5-HT2A = LSD
  • antagonist at 5-HT2A = antipsychotics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

access of drugs to the CNS (BBB)

A
  • BBB consists of endothelial cells and astrocytes
  • endothelial = blood component of BBB
  • astrocytes = support cells in the CNS
  • some drugs cannot pass though the BBB
  • transport of drugs occurs via passove diffusion
17
Q

common neurodegenerative disorders

A

Alzheimers = loss od cholenergic neurons
Parkinsons = loss of dopaminergic neurons

18
Q

neurodegenerative disorders

A
  • progressive loss of specific population of neurons determines symptoms
  • no cures available
  • drugs used to enhance communication between remaining neurons
  • with severe neuron loss, some drugs no longer effective at treating symptoms
19
Q

symptoms of Alzheimers

A
  • progressive and irreversible memory loss (decreased cholinergic input to hippocampus)
  • cognitive impairment (decreased cholinergic input to cortex)
20
Q

Pathological changes in AD brain

A
  • Neurofibrillary tangles = intracellular accumulation of twisted fibres of phosphorylated tau protein
  • Plaques = extracellular deposits of beta-amyloid protein
21
Q

Treatment of Alzheimers

A
  • aimed at restoring neuron communication and improving symptoms
  • AChE inhibitors (donepezil) are the drugs used
  • easily enter CNS and inhibit breakdown of ACh
  • effective for mild-moderate AD
  • side effects same as peripheral acting AChE inhibitors
22
Q

how Donepezil works in Alzheimers

A
  • inhibits AChE so ACh is not degraded
  • more ACh can bind to M receptors at cortex
  • causes increased Ca2+ and leads to improved memory